This Division is about price reductions for listed brands of pharmaceutical items.

Subdivision B requires there to be a price reduction for the first new brand of a pharmaceutical item (other than a combination item) when the brand lists. The listing of the new brand of the pharmaceutical item also provides an automatic trigger for price reductions to occur under Subdivision E (see sections   99ACQ and 99ACR).

Subdivision C requires there to be a price reduction for the first new brand of a pharmaceutical item that is a combination item when the brand lists. The listing of the new brand of the pharmaceutical item also provides an automatic trigger for price reductions to occur under Subdivision E (see sections   99ACQ and 99ACR).

Subdivision D provides for other price reductions for pharmaceutical items. These price reductions include reductions that occur on a certain anniversary of the drug in the pharmaceutical item being a listed drug.

Subdivision E provides for price reductions that are automatically triggered when Subdivision B or C applies to require a first new brand price reduction for a brand of a pharmaceutical item.

Price reductions for listed brands of pharmaceutical items under this Division are subject to:

(a)   determinations made by the Minister to not apply, or reduce, the price reduction; or

(b)   price reductions made under Subdivision E of Division   3B (see section   99ACG).